What is Tenaya Therapeutics Inc (TNYA) stock price today?

Tenaya Therapeutics Inc (TNYA) currently trades at $0.69 per share. The stock has a market capitalization of $145.87M and a P/E ratio of —x.

Is TNYA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Tenaya Therapeutics Inc has a Smart Value Score of 28/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -6.00.

Is Tenaya Therapeutics Inc financially healthy?

Tenaya Therapeutics Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -6.00 places it in the distress.

TNYA

Tenaya Therapeutics Inc

NASDAQ: TNYA · HEALTHCARE · BIOTECHNOLOGY

$0.69

+4.66% today

Updated 2026-04-30

Market cap

$145.87M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.59

Dividend yield

—

52W range

$0 – $2

Volume

4.3M

Market cap

$145.87M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.59

Dividend yield

—

52W range

$0 – $2

Volume

4.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-6.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$9.00

+1202.27%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.14x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -6.00 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-14.01M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-123.66M	$-124.08M	$-111.13M	$-90.60M	$-20.18M
EPS	—	—	—	—	$-0.59
Free cash flow	$-125.05M	$-103.31M	$-91.53M	$-68.88M	$-14.01M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
TNYA	$145.87M	28	4.3	3.0	5.0	6.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Tenaya Therapeutics Inc trades at $0.69. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -6.00, it sits in the distress.

Frequently asked questions

What is Tenaya Therapeutics Inc's stock price?

Tenaya Therapeutics Inc (TNYA) trades at $0.69.

Is Tenaya Therapeutics Inc overvalued?

Smart Value Score 28/100 (Grade F, Strong Sell).

What is the price target of Tenaya Therapeutics Inc (TNYA)?

The analyst target price is $9.00, representing +1202.3% upside from the current price of $0.69.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-6.00 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.tenayatherapeutics.com

Quick metrics

P/S ratio—

ROE-83.80%

Beta3.00

50D MA$0.72

200D MA$1.03

Shares out0.22B

Float0.17B

Short ratio—

Avg volume4.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

TNYA vs LLY →TNYA vs JNJ →TNYA vs ABBV →Stock screener →